Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4396939 | 0.91 | THRB (0.31) | THRB | |
| SCHEMBL211012 | 0.91 | THRB (0.33) | THRB | |
| Sulfuric Acid Dimethyl Ester SCHEMBL462142 | 0.90 | — | — | |
| SCHEMBL4400065 | 0.88 | — | — | |
| SCHEMBL8358756 | 0.86 | TSHR (0.35) | THRB | |
| SCHEMBL31513756 | 0.86 | THRB (0.32) | THRB | |
| SCHEMBL6396065 | 0.84 | TSHR (0.37) | THRB | |
| SCHEMBL8356933 | 0.84 | TSHR (0.37) | THRB | |
| SCHEMBL1768626 | 0.82 | CHRM2 (0.36) | THRB | |
| SCHEMBL28333248 | 0.81 | THRB (0.41) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580751-A2 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | Adora Animal Health Corporation (US) | 2025-07-09 | — | — | EP | claimed |
| US-12303528-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2025-05-20 | — | — | US | claimed |
| US-20240342208-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2024-10-17 | — | — | US | claimed |
| WO-2024072942-A2 | SKIN PENETRATING FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA ANIMAL HEALTH CORPORATION (US) | 2024-04-04 | — | — | WO | claimed |
| JP-8310918-A | — | — | None | — | — | JP | disclosed |
| US-12636308-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12636309-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | ADORA ANIMAL HEALTH CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| US-12584080-B2 | Gel-like shaped body for fragrancing textiles during the washing process | HENKEL AG & CO. KGAA (DE) | 2026-03-24 | — | — | US | disclosed |
| US-20260069607-A1 | Progestin/Testosterone Transdermal Gel | THE POPULATION COUNCIL, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-12502395-B2 | Progestin/testosterone transdermal gel | THE POPULATION COUNCIL, INC. (US) | 2025-12-23 | — | — | US | disclosed |
| US-20250249030-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2025-08-07 | — | — | US | disclosed |
| US-20250249031-A1 | STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS | ADORA LIFE SCIENCE, INC. | 2025-08-07 | — | — | US | disclosed |
| WO-1998015254-A1 | COSMETIC OR DERMATOLOGICAL MICROEMULSION BASED GELS | BEIERSDORF AG (DE) | 1998-04-16 | — | — | WO | disclosed |
| WO-1998015255-A1 | COSMETIC OR DERMATOLOGICAL MICROEMULSIONS | BEIERSDORF AG (DE) | 1998-04-16 | — | — | WO | disclosed |
| EP-0814752-A2 | COSMETIC OR PHARMACEUTICAL MICROEMULSIONS | Beiersdorf Aktiengesellschaft (DE) | 1998-01-07 | — | — | EP | disclosed |
| EP-0814753-A2 | COSMETIC OR DERMATOLOGICAL GELS BASED ON MICROEMULSIONS | Beiersdorf Aktiengesellschaft (DE) | 1998-01-07 | — | — | EP | disclosed |
| EP-0793956-A1 | Hair cosmetic composition containing phytosterols and alpha-hydroxy acids | Beiersdorf Aktiengesellschaft (DE) | 1997-09-10 | — | — | EP | disclosed |
| JP-H08310918-A | HAIR COSMETIC | SHISEIDO CO LTD | 1996-11-26 | — | — | JP | disclosed |
| WO-1996028131-A2 | COSMETIC OR PHARMACEUTICAL MICROEMULSIONS | BEIERSDORF AG (DE) | 1996-09-19 | — | — | WO | disclosed |
| WO-1996028132-A2 | COSMETIC OR DERMATOLOGICAL GELS BASED ON MICROEMULSIONS | BEIERSDORF AG (DE) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584080-B2 | Gel-like shaped body for fragrancing textiles during the washing process | ADH1C, AKR1C3, AKR1C4 | THRB 4269/4885 |
| US-12636308-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | FUT6, CD44, CSGALNACT1 | THRB 2115/4885 |
| US-12636309-B2 | Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions | CD44, FUT8, FUT6 | THRB 1290/4885 |
| US-20260069607-A1 | Progestin/Testosterone Transdermal Gel | SHBG, CYP17A1, HSD17B11 | THRB 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.